OncoSec Medical Inc (ONCSQ)

[chickpea598]

More info about speaker sessions: Our man Pierce will be there too.

Biomarkers and Precision Medicine USA Congress Day 2 – 4th October 2016

14.00 – 14.30
Biomarker Development for Intratumoral Gene Therapy with DNA-encoded IL-12
Patient selection biomarkers for low TIL/low anti-PD1 responder population
Pharmacodynamic (PD) biomarkers of effective in-situ vaccination
Robert Pierce, Chief Scientific Strategist, OncoSec Medical




15.30 – 16.00
Panel Discussion- Immuno-oncology Biomarker Development
Challenges in Precision medicine
Status of PDL1 assay and biomarker development and other pathways
Non Respondence of PDL1
Lessons learnt
Chair: Adil Daud, Professor of Medicine, University of California, San Francisco
Panellists:
Robert Pierce, Chief Scientific Strategist, OncoSec Medical Chan Whiting, Associate Director, Aduro Biotech

http://www.biomarkersusa-congress.com/wordpress/wp-content/uploads/2016/09/BF-Biomarkers-and-Precision-Medicine-USA-090916.pdf

NICE!